8:30 Keynote with U.S. Congressman Dana Rohrabacher
Congressman Dana Rohrbacher (Republicans) heads the subcommittee on Foreign Affairs focused on Europe and Eurasia in the U.S. House of Representatives. The Californian representative is the co-initiator of the Rohrbacher-Farr resolution which was adopted in 2014. It prohibits the justice department to fund resources that interfere with the implementation of state medical marijuana laws.
9:15 Global Medical Cannabis Research
As more peer reviewed research for cannabis is being conducted internationally, it is not a question anymore if cannabis can help patients, rather, it is a question of what types of cannabis are good for what types of ailments, and the most efficient administration methods. Learn the latest breakthroughs and cutting edge science from around the world.
10:30 Medical Marijuana Rules and Regulations in Germany (Patients, Pharmacies and LPs)
The first licenses for the cultivation of medical cannabis will soon be given out by a federal cannabis agency. Also, acquiring your medical cannabis prescription will soon become a less cumbersome process for patients and doctors. We will delve into the process of becoming a German licensed producer, discuss the process of becoming a medical cannabis patient in Germany, as well as go over the pharmacies’ role as conduits between licensed producers and patients.
11:30 Extractions and Concentrates
Extractions are becoming a massive share of the market in the U.S. Currently, Germany’s medical cannabis patients only have access to flowers. Under the new German laws, extractions will be allowed to be sold in pharmacies. We will go over the most cutting edge, clean and efficient extraction methods and their alternate benefits and discuss how extractions will be implemented into the German market.
13:30 Dr. Franjo Grotenhermen MD
It took patients 17 years to change the law in favor of medical cannabis. Dr. Franjo Grotenhermen is a MD and an internationally sought after cannabinoid-specialist, supporting Germany’s cannabis patients since over two decades. Dr. Grotenhermen will explain the basics of medical cannabis and its scientific background, while focusing on patients health and their right to safe and reliable medicine
14:30 Testing and Standardization
From seed to sale, what are the best practices for standardizing cannabis for public consumption? Learn from testing models in other respective jurisdictions and experts on production as to what is currently working in terms of delivering a safe and contaminant free product to market.
15:45 Entourage Effect
In its natural state, over 90% of cannabinoids produced by cannabis plants come in acidic forms. Acidic cannabinoids, such as cannabidiolic acid (CBDA), tetrahydrocannabinol acid (THCA), cannabigerolic acid (CBGA) and their functions remain largely overlooked. This talk will critically review experimental evidence of the therapeutic potential of acidic cannabinoids—as well as discuss the experimental and clinical evidence of the cannabis entourage effect—emphasizing the importance of the interactions between acidic and neutral phytocannabinoids, terpenes, and other compounds found in cannabis plants.
16:15 Celebrity Interview – TBA
Stay tuned for more information.
9:00 Keynote TBA
9:45 Lobbying for Cannabis
It is no fluke that cannabis policy is changing around the world. Grassroots activists have been campaigning for fifty years to achieve the results we are currently seeing. Not only is advocating on the behalf of cannabis legalization the right thing to do, it is good practice for businesses in their respective communities. Our cannabis advocate experts will go over what steps it has taken to get to this point, as well as tips on future advocacy strategies and tactics.
11:00 Cannabis and Media
Cannabis is a growingly hot topic in the media. The industry is beginning to boom worldwide and eighty years of prohibition is fading. As marijuana has become more mainstream, the media has adapted to reflect this new paradigm. Our panel of experts will provide a lay of the land for cannabis in the media, providing insight for business people and advocates of a landscape that continues to evolve and gain more acceptance across the globe.
12:00 Consumer Tech and Branding
Cannabis has gone mainstream, which means ratcheting up innovation and focusing on brand are crucial factors for success. Our panel features cannabis industry disrupters discussing the new competitive paradigm, with a focus on applicable German business models.
14:00 Genetics: Globalization and Commercialization
As a growing number of countries legalize cannabis and set the groundwork for international commerce, the questions of plant breeders’ rights and Intellectual Property (IP) become paramount. Our panel will feature iconic breeders and leading legal minds examining the impact of global commercialization on plant genetics and IP.
15:00 Cannabis Cultivation and New Technologies
In the last 30 years, many innovations in the cultivation of cannabis have been developed. International commercial growers and producers will report the most efficient, smart and healthy ways to grow cannabis while considering scalability.
16:00 Public Markets Financing and Cannabis Stocks
With investor interest in cannabis at an all-time high, our panel will discuss the possibilities of public cannabis companies in Germany, as well as opportunities in more established areas as Canada. Our panel will include analysts along with COEs of cannabis pub-cos.